Bank Of New York Mellon Corp Bolt Biotherapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.29 - $1.66 $16,291 - $20,964	12,629 New	12,629 $17.6 Million
Q4 2022 Feb 14, 2023	BUY	$1.26 - $1.51 $15,912 - $19,069	12,629 New	12,629 $16,000
Q3 2022 Nov 14, 2022	SELL	$1.48 - $2.61 $251 - $443	-170 Reduced 1.32%	12,685 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.41 - $2.91 $110,597 - $228,254	-78,438 Reduced 85.92%	12,855 $26,000
Q1 2022 May 11, 2022	BUY	$2.74 - $4.82 $28,701 - $50,489	10,475 Added 12.96%	91,293 $249,000
Q4 2021 Feb 11, 2022	BUY	$4.19 - $13.97 $42,838 - $142,829	10,224 Added 14.48%	80,818 $397,000
Q3 2021 Nov 12, 2021	BUY	$11.15 - $18.6 $267,321 - $445,935	23,975 Added 51.43%	70,594 $893,000
Q2 2021 Aug 11, 2021	BUY	$15.4 - $31.46 $223,946 - $457,491	14,542 Added 45.33%	46,619 $720,000
Q1 2021 May 13, 2021	BUY	$25.86 - $39.93 $829,511 - $1.28 Million	32,077 New	32,077 $1.06 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.4M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.